Treatment of hereditary angioneurotic oedema (HANE) with tibolone

Clinical Endocrinology

Volumn 66, Issue 2, 2007, Pages 180-184

  Ott, H W ^a,e   Mattle, V ^a   Hadziomerovic, D ^a   Licht, P ^b   Doinghaus K ^b   Rubbert, A ^c,d   Manger, K ^c   Manger, B ^c   Kalden, J ^c   Wildt, L ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BERINERT; COMPLEMENT COMPONENT C1S INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID; TIBOLONE; UNCLASSIFIED DRUG;

ACNE; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; PALLIATIVE THERAPY; PILOT STUDY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VIRILIZATION;

ADULT; ANGIONEUROTIC EDEMA; COMPLEMENT C1 INACTIVATOR PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NORPREGNENES; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 33846257234     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02704.x     Document Type: Article

References (43)

1. Bork, K. & Barnstedt, S.E. (2001) Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Archives of Internal Medicine, 161, 714-718.
2. Bork, K., Fischer, B. & Dewald, G. (2003) Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. American Journal of Medicine, 114, 294-298.
3. Chowdhury, B.A. (2002) Chronic urticaria and angioedema. New England Journal of Medicine, 347, 20-221.
4. Cicardi, M., Bergamaschini, L., Marasini, B., Boccassini, G., Tucci, A. & Agostoni, A. Hereditary angioedema: an appraisal of 104 cases. American Journal of the Medical Sciences, 284, 2-9.
5. Donaldson, V.H. & Rosen, F.S. (1964) Action of complement in hereditary angioneurotic edema: the role of C′-1-esterase. Journal of Clinical Investigation, 43, 2204-2213.
6. Eck, S.L., Morse, J.H., Janssen, D.A., Emerson, S.G. & Markovitz, D.M. (1993) Angioedema presenting as chronic gastrointestinal symptoms. American Journal of Gastroenterology, 88, 436-439.
7. Elnicki, D.M. (1992) Hereditary angioedema. Southern Medical Journal, 85, 1084-1090.
8. Frigas, E. (1989) Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes. Mayo Clinic Proceedings, 64, 1269-1275.
9. Pichler, W.J., Lehne, R. & Spaeth, P.J. (1989) Recurrent angioedema associated with hypogonadism or anti-androgen therapy. Annals of Allergy, Asthma and Immunology, 63, 301-305.
10. Kashyap, A.S. & Kashyap, S. (2002) Hereditary angioedema and hormones. Archives of Internal Medicine, 162, 2142.
11. Bork, K., Meng, G., Staubach, P. & Hardt, J. (2006) Hereditary angioedema: new findings concerning symptoms, affected organs, and course. American Journal of Medicine, 119, 267-274.
12. Bork, K., Kreuz, W. & Witzke, G. (1984) Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy [in German]. Deutsche Medizinische Wochenschrift, 109, 1331-1335.
13. Farkas, H., Harmat, G., Gyeney, L., Fuest, G. & Varga, L. (1999) Danazol therapy for hereditary angio-oedema in children. Lancet, 354, 1031-1032.
14. Alper, C.A. (1978) The 'cure' of an inherited disease. Journal of Laboratory and Clinical Medicine, 92, 497-500.
15. Atkinson, J.P. (1997) Diagnosis and management of hereditary angioedema (HAE). Annals of Allergy, Asthma and Immunology, 42, 348-352.
16. Farkas, H., Gyeney, L., Gidofalvy, E., Fust, G. & Varga, L. (1998) Efficacy of short-term danazol treatment in hereditary angioneurotic edema patients undergoing maxillofacial and dental surgical procedures. Fogorvosi Szemle, 91, 171-178.
17. Frank, M.M. (1982) The C1 esterase inhibitor and hereditary angioedema. Journal of Clinical Immunology, 2, 65-68.
18. Hosea, S.W. & Frank, M.M. (1980) Danazole in the treatment of hereditary angioedema. Drugs, 19, 370-372.
19. Robinson, L.C. & Hart, L.L. (1992) Danazol in hereditary angioedema. Annals of Pharmacotherapy, 26, 1251-1252.
20. Sheffer, A.L., Fearon, D.T. & Austen, K.F. (1988) Hereditary angioedema: a decade of management with stanozolol. Journal of Allergy and Clinical Immunology, 80, 855-860.
21. Schwarz, S., Tappeiner, G. & Hintner, H. (1981) Hormone binding globulin levels in patients with hereditary angiooedema during treatment with danazol. Clinical Endocrinology, 14, 563-570.
22. Spaulding, W.B. (1960) Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Annals of Internal Medicine, 53, 739-745.
23. Döinghaus, K., Rubbert, A., Manger, B. & Wildt, L. (1992) Hereditary angioedema: preventive therapy with testosterone per os instead of danazol. A case report. Acta Endocrinologica, 126 (Suppl. 4), 115.
24. Gadek, J.E., Hosea, S.W., Gelfand, J.A., Santaella, M. & Wickerhauser, M. (1980) Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. New England Journal of Medicine, 302, 542-546.
25. Khorram-Sefat, R., Goldmann, C., Radke, A., Lennartz, A. & Mottaghy, K. (1998) The therapeutic effect of C1-inhibitor on gut-derived bacterial translocation after thermal injury. Shock, 9, 101-108.
26. Pickering, R.J., Good, R.A., Kelly, J.R. & Gewurz, H. (1969) Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lancet, 1, 326-330.
27. Waytes, A.T., Rosen, F.S. & Frank, M.M. (1996) Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. New England Journal of Medicine, 334, 1630-1634.
28. Duck, S.C. & Katayama, K.P. (1981) Danazol may cause female pseudohermaphroditism. Fertility and Sterility, 35, 230-231.
29. Gelfand, J.A., Sherins, R.J., Alling, D.W. & Frank, M.M. (1976) Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. New England Journal of Medicine, 295, 1444-1448.
30. Helsing, P. & Nielsen, E.W. (2002) Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema. Acta Dermato-Venereologica, 86, 272-273.
31. Bartley, J., Loddenkemper, C., Lange, J., Mechsner, S., Radke, C., Neuhaus, P. & Ebert, A.D. (2004) Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report. Archives of Gynecology and Obstetrics, 269, 290-293.
32. Szeplaki, G., Varga, L., Valentin, S., Kleiber, M., Karadi, I., Romics, L., Fust, G. & Farkas, H. (2005) Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. Journal of Allergy and Clinical Immunology, 115, 864-869.
33. Zawar, V. & Sankalecha, C. (2004) Facial hirsutism following danazol therapy. Cutis, 74, 301-303.
34. Markiewicz, L. & Gurpide, E. (1990) In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. Journal of Steroid Biochemistry, 35, 535-541.
35. Nevinny-Stickel, J. (1983) Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients. Archives of Gynecology and Obstetrics, 234, 27-31.
36. Trevoux, R., Dieulangard, P. & Blum, A. (1983) Efficacy and safety of Org OD 14 in the treatment of climacteric complaints. Maturitas, 5, 89-96.
37. Braun, P., Leyendecker, G. & Nocke, W. (1997) Danazol - Pharmacological, basic and clinical application. Der Gynäkologe, 12, 219-227.
38. Egarter, C., Hube, J., Leikermoser, R., Haidbauer, R. & Pusch, H. (1996) Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas, 23, 55-62.
39. Sandker, G.W., Vos, R.M., Delbressine, L.P., Slooff, M.J., Meijer, D.K. & Groothuis, G.M. (1994) Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica, 24, 143-155.
40. Tang, B., Markiewicz, L., Kloosterboe, H.J. & Gurpide, E. (1993) Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14). Journal of Steroid Biochemistry and Molecular Biology, 45, 345-351.
41. Donaldson, V.H. (1989) C1-inhibitor in hereditary angioneurotic edema: types I and II. Behring Institute Mitteilungen, 1989, 151-160.
42. Donaldson, V.H. (1993) C1-inhibitor and its genetic alterations in hereditary angioneurotic edema. International Reviews of Immunology, 10, 1-16.
43. Franchimont, P., Franchi, F., Luisi, M. & Kicovic, P.M. (1982) Ovulation-inhibiting properties of Org OD 14. Reproduction, 6, 61-67.